Prof Rob Bryant
School of Medicine
College of Health
Eligible to supervise Masters and PhD as Principal Supervisor - email supervisor to discuss availability.
Associate Professor Robert Bryant is Head of the Inflammatory Bowel Disease service at The Queen Elizabeth Hospital, Research Lead at the Basil Hetzel Institute, Chair of the Gastroenterology Network of Intestinal Ultrasound (GENIUS), a member of the GESA IBD Faculty, and Clinical Associate Professor at the University of Adelaide. Rob undertook a Clinical Fellowship in Inflammatory Bowel Diseases (IBD) at the John Radcliffe Hospital in Oxford, after which he completed a Master of Science by Research (MScR) at the University of Oxford in the field of genetics and mucosal immunology in IBD. He thereafter completed a PhD at the University of Adelaide in the area of treatment targets in IBD, for which he was awarded a University Medal. Rob leads the intestinal ultrasound service at TQEH and coordinates a clinical and translational research program exploring microbial therapy in IBD, both through diet and faecal microbial transplantation. He has been awarded the Michell McGrath Fellowship from The Hospital Research Foundation to pursue microbial manipulation in IBD.
| Date | Position | Institution name |
|---|---|---|
| 2023 - ongoing | Michell McGrath Fellow | Basil Hetzel Institute |
| 2018 - ongoing | Clinical Senior Lecturer | University of Adelaide |
| 2017 - ongoing | Staff Specialist Gastroenterologist, Head of Inflammatory Bowel Diseases | Queen Elizabeth Hospital |
| 2016 - ongoing | Basic Physician Training Clinical tutor and examiner | Queen Elizabeth Hospital |
| 2016 - ongoing | Clinical Lecturer, Medical School Lecture Series | University of Adelaide |
| 2016 - 2016 | Gastrointestinal Ultrasound Fellowship | Sacco University Hospital |
| 2015 - 2018 | Lecturer | SAPMEA Postgraduate Medical Education Association lectures |
| 2015 - 2017 | Consultant Gastroenterologist | Royal Adelaide Hospital |
| 2015 - ongoing | Visiting Medical Specialist | Alice Springs Hospital |
| 2014 - 2015 | Clinical Research Fellow | University of Oxford |
| 2013 - 2015 | Senior Clinical Fellow in Gastroenterology | John Radcliffe Hospital |
| 2011 - 2013 | Gastroenterology Advanced Trainee | Royal Adelaide Hospital |
| 2011 - 2012 | Academic and clinical tutor, Basic Physician Training Program | Royal Adelaide Hospital |
| 2011 - 2012 | Guest lecturer and bedside tutor | University of Adelaide |
| 2008 - 2011 | Basic Physician Trainee | Royal Adelaide Hospital |
| 2007 - 2007 | Resident Medical Officer | Royal Hobart Hospital |
| 2006 - 2006 | Internship | Royal Perth Hospital |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2016 | Scholarship | AR Clarkson Scholarship | Royal Adelaide Hospital Research Committee | Australia | - |
| 2012 | Award | Mark Jolly Foundation Fellowship Award | Royal Adelaide Hospital | Australia | - |
| 2012 | Award | Professor Derek Frewin Clinical Teaching Award | School of Medicine, University of Adelaide | Australia | - |
| 2010 | Award | Professor Derek Frewin Clinical Teaching Award | School of Medicine, University of Adelaide | Australia | - |
| 2004 | Award | Meritous award for Geriatrics | School of Medicine, University of Adelaide | Azerbaijan | - |
| 2004 | Award | Meritous Award for Obstetrics and Gynaecology | School of Medicine, University of Adelaide | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2015 - 2018 | University of Adelaide | Australia | PhD |
| 2014 - 2015 | University of Oxford | United Kingdom | Master of Science (by Research) MScR |
| 2005 | University of Adelaide | Australia | Bachelor of Medicine, Bachelor of Surgery (MBBS) |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2014 - 2015 | Master of Science by Research (MScR) | University of Oxford | United Kingdom |
| 2011 - 2013 | Fellowship of the Royal Australasian College of Physicians (FRACP) | Royal Australasian College of Physicians | Australia |
| Year | Citation |
|---|---|
| 2026 | Bogatic, D., Sparrow, M. P., Boyapati, R. K., & Bryant, R. V. (2026). Balancing costs and care: evaluating the need for novel therapies for immune-mediated inflammatory diseases in Australia. Internal Medicine Journal, 56(1), 116-121. |
| 2026 | Davis, R. H., Bryant, R. V., Gibson, P. R., & Day, A. S. (2026). The fate of dietary protein in the gastrointestinal tract and implications for colonic disease. Nature Reviews Gastroenterology and Hepatology, 23(5), 381-394. Scopus5 WoS3 Europe PMC3 |
| 2026 | Plush, S., Bryant, R. V., Davis, R. H., Kumar, S., & Day, A. S. (2026). Nutrient requirements for adults with ulcerative colitis over the disease course: a systematic scoping review. Critical Reviews in Food Science and Nutrition, 66(21), 4010-4021. |
| 2026 | Jairath, V., Vuyyuru, S. K., Zou, G., Ma, C., Neustifter, B., Agboton, C., . . . Maaser, C. (2026). Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial. BMJ Open Gastroenterology, 13(1), 13 pages. Scopus1 WoS1 |
| 2026 | Bogatic, D., Costello, S. P., & Bryant, R. V. (2026). Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Alimentary Pharmacology and Therapeutics, 64(3), 412-413. Scopus1 WoS1 Europe PMC2 |
| 2026 | Chen, L., Ruddick-Collins, L., An, Y. K., Baraty, B., Begun, J., Boyapati, R. K., . . . Srinivasan, A. R. (2026). Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists. Therapeutic Advances in Gastroenterology, 19, 11 pages. Scopus3 WoS2 Europe PMC2 |
| 2026 | Day, A. S., Ballard, T. M., Benetti, M., Halmos, E., Gibson, P. R., Yao, C. K., & Bryant, R. V. (2026). Development and Evaluation of a Sham Diet Intended as a Placebo-Control Diet for Food-Based Interventional Trials in Ulcerative Colitis. Journal of the Academy of Nutrition and Dietetics, 126(7), 15 pages. Scopus1 WoS1 Europe PMC1 |
| 2026 | Mathias, R. M., Bogatic, D., Edwards, L., Bibb, L., Van Oosterwyck, A., Edwards, S., . . . Bryant, R. V. (2026). Intestinal ultrasound reliably predicts fecal loading in patients with ulcerative colitis. Journal of Crohn S and Colitis, 20(5), 9 pages. |
| 2026 | Plush, S. L., Litwin, P., Han, S., Bryant, R. V., Kumar, S., Kaazan, P., & Day, A. S. (2026). Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease. Current Diabetes Reports, 26(1), 16 pages. |
| 2026 | Collins, K., Kamath, S., Davis, R. H., Costello, S. P., Bryant, R. V., Day, A. S., & Joyce, P. (2026). Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy. Alimentary Pharmacology and Therapeutics, 64(6), 729-747. |
| 2026 | Ngoi, B., Duong, T. A., Bryant, R. V., Andrews, J. M., & Lynch, K. D. (2026). Corticosteroid therapy following infliximab rescue in acute severe ulcerative colitis: should they be continued?. Internal Medicine Journal, 3 pages. |
| 2026 | Raja, S. S., Costello, S. P., Sadler, A., Wan, N., Tandon, B., Sathananthan, D., . . . Bryant, R. V. (2026). The Proctitis Paradox: Refractory Ulcerative Proctitis Associated With Development of Disease Complications in a Multicenter South Australian Cohort. Jgh Open, 10(9), 9 pages. |
| 2025 | Day, A. S., Ballard, T. M., Yao, C. K., Gibson, P. R., & Bryant, R. V. (2025). Food-Based Interventions as Therapy for Inflammatory Bowel Disease: Important Steps in Diet Trial Design and Reporting of Outcomes. Inflammatory Bowel Diseases, 31(4), 1121-1137. Scopus8 WoS8 Europe PMC5 |
| 2025 | Goodsall, T. M., An, Y. K., Andrews, J. M., Begun, J., Friedman, A. B., Lee, A., . . . Bryant, R. V. (2025). Reliability of Intestinal Ultrasound for Evaluating Crohn's Disease Activity Using Point-of-care and Central Reading. Clinical Gastroenterology and Hepatology, 23(9), 1600-1611.e9. Scopus24 WoS20 Europe PMC19 |
| 2025 | Mathias, R. M., Plush, S. L., Fairhead, E. J. S., Ngoi, B., Edwards, L., Day, A. S., & Bryant, R. V. (2025). Patients with functional gastrointestinal disorders spend less time in tertiary care when managed by a single clinician: results of a multicentre audit in South Australia. Internal Medicine Journal, 55(2), 260-269. Scopus1 WoS2 Europe PMC2 |
| 2025 | Griffiths, B. J., Desborough, M. J. R., Duijvestein, M., D'Haens, G. R. A., Yuan, Y., Bryant, R. V., . . . Jairath, V. (2025). Hypercoagulation After Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study. Clinical Gastroenterology and Hepatology, 23(10), 1798-1807.e5. Scopus6 WoS6 Europe PMC3 |
| 2025 | Gilmore, R., Fernandes, R., Hartley, I., Arzivian, A., Leong, R., Andrew, B., . . . Begun, J. (2025). Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study. Intestinal Research, 23(3), 347-357. Scopus16 WoS17 Europe PMC16 |
| 2025 | Chu, M. K. W., Day, A. S., Broad, L., Costello, S. P., Edwards, S., & Bryant, R. V. (2025). Meta-Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis. Alimentary Pharmacology and Therapeutics, 61(5), 756-775. Scopus11 WoS10 Europe PMC9 |
| 2025 | Yao, C. K., Green, K., Day, A. S., Ardalan, Z. M., Slater, R., Bryant, R. V., . . . Probert, C. (2025). Distinct Profiles of Fecal Volatile Organic Compounds Discriminate Ulcerative Colitis Patients With an Ileoanal Pouch From Those With an Intact Colon. Molecular Nutrition and Food Research, 69(7), 10 pages. Scopus4 WoS4 Europe PMC4 |
| 2025 | Chu, M. K. W., Day, A. S., Broad, L., Costello, S. P., Edwards, S., & Bryant, R. V. (2025). Letter: Exclusive Enteral Nutrition in Ulcerative Colitis-The Path Ahead Needs Careful Consideration. Authors' Reply.. Alimentary pharmacology & therapeutics, 61(9), 1579-1580. |
| 2025 | Li, A., Costello, S. P., Bryant, R. V., Haylock-Jacobs, S., Haifer, C., Lee, C., . . . Wardill, H. R. (2025). A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study. BMC Cancer, 25(1), 656-1-656-8. Scopus1 WoS1 |
| 2025 | Fehily, S. R., Wright, E. K., Basnayake, C., Wilson-O'Brien, A. L., Stanley, A., Marks, E. P., . . . Kamm, M. A. (2025). Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol. BMJ Open, 15(4), e094714-1-e094714-10. Scopus3 Europe PMC3 |
| 2025 | Kamath, S., Bryant, R. V., Costello, S. P., Day, A. S., Forbes, B., Haifer, C., . . . Joyce, P. (2025). Translational strategies for oral delivery of faecal microbiota transplantation.. Gut, online(12), gutjnl-2025-335077. Scopus25 WoS25 Europe PMC10 |
| 2025 | Mathias, R. M., Goodsall, T. M., Parker, C. E., Day, A. S., An, Y. K., Baraty, B., . . . Bryant, R. V. (2025). Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading. Alimentary Pharmacology and Therapeutics, 62(8), 799-808. Scopus9 WoS8 Europe PMC3 |
| 2025 | De Sciscio, M., Bryant, R. V., Haylock-Jacobs, S., Day, A. S., Pitchers, W., Iansek, R., . . . Kimber, T. E. (2025). Faecal microbiota transplant in Parkinson’s disease: pilot study to establish safety & tolerability. Npj Parkinson S Disease, 11(1), 6 pages. Scopus14 WoS15 Europe PMC10 |
| 2025 | Chu, M. K. W., Day, A. S., Bogatic, D., Hatzi, M., Chu, S. K. S., Costello, S. P., & Bryant, R. V. (2025). Frequent Dietetic Involvement Enhances Adherence and Clinical Outcomes of Exclusive Enteral Nutrition in Adults With Crohn's Disease. Jgh Open, 9(7), 14 pages. Scopus3 WoS3 Europe PMC3 |
| 2025 | Day, A. S., & Bryant, R. V. (2025). Letter: Diet to Modify Risk of IBD—More Plants and Less Processed Food?. Alimentary Pharmacology and Therapeutics, 62(5), 557-558. |
| 2025 | Portmann, L. J., Fitzpatrick, J. A., Halmos, E. P., Bryant, R. V., & Day, A. S. (2025). Looking Beyond Nutrients, How to Assess Diet Quality in an Inflammatory Bowel Disease Population—A Narrative Review. Nutrients, 17(14), 20 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Mathias, R. M., Goodsall, T. M., Parker, C. E., Day, A. S., An, Y. K., Baraty, B., . . . Bryant, R. V. (2025). Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply. Alimentary Pharmacology and Therapeutics, 62(8), 855-856. |
| 2025 | Day, A. S., Slater, R., Young, R. B., Wheeler, R. Z., Marcelino, V. R., Maddigan, N. K., . . . Bryant, R. V. (2025). Functional Profiling Demonstrates That a Sulfide-Reducing Diet Achieves Microenvironmental Targets in Ulcerative Colitis.. Inflamm Bowel Dis, 31(11), 3160-3171. Scopus10 WoS9 Europe PMC7 |
| 2025 | Raja, S. S., Costello, S. P., Rayner, C. K., Day, A., Portmann, L., Uylaki, W., . . . Bryant, R. V. (2025). Examining the role of faecal microbiota transplantation for inducing remission in resistant ulcerative proctitis and distal ulcerative colitis (up-FMT).. J Crohns Colitis, 19(10), 13 pages. Scopus3 WoS3 Europe PMC1 |
| 2025 | Mathias, R. M., Bogatic, D., & Bryant, R. V. (2025). Editorial: Is Disease Clearance the Target in Ulcerative Colitis or a Stride Too Far?. Alimentary Pharmacology and Therapeutics, 62(11-12), 1220-1221. Europe PMC1 |
| 2025 | Hanžel, J., Solitano, V., Vuyyuru, S. K., Panaccione, R., Sands, B. E., Peyrin-Biroulet, L., . . . Ma, C. (2025). An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Gastroenterology, 169(6), 1282-1293. Scopus6 Europe PMC4 |
| 2025 | Law, C. C. Y., Sheskier, R., Viera-Feliciano, N., Delgado-Nieves, A., Seth, S., Hanžel, J., . . . Jairath, V. (2025). Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion. Inflammatory Bowel Diseases, 31(11), 3077-3092. Scopus3 Europe PMC2 |
| 2025 | An, Y. K., Lindsay, N., Allan, N., Khoo, E., Fernandes, R., Gilmore, R., . . . Begun, J. (2025). Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium. Jgh Open, 9(12), 18 pages. Scopus2 WoS2 Europe PMC1 |
| 2024 | Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity. Intestinal Research, 22(1), 104-114. Scopus18 WoS18 Europe PMC14 |
| 2024 | Russell, E. E., Day, A. S., Dimitroff, C., Trakman, G. L., Silva, H., Bryant, R. V., . . . Fitzpatrick, J. A. (2024). Practical application of the Crohn's disease exclusion diet as therapy in an adult Australian population. Journal of Gastroenterology and Hepatology Australia, 39(3), 446-456. Scopus17 WoS17 Europe PMC16 |
| 2024 | Schubert, J. P., Ingram, P. R., Warner, M. S., Rayner, C. K., Roberts-Thomson, I. C., Costello, S. P., & Bryant, R. V. (2024). Author reply to Hettiarachchi et al. (re Helicobacter pylori resistance in Australia…). Internal Medicine Journal, 54(2), 356-357. |
| 2024 | Lu, C., Rosentreter, R., Delisle, M., White, M., Parker, C., Premji, Z., . . . Rieder, F. (2024). Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary Pharmacology and Therapeutics, 59(8), 928-940. Scopus42 WoS43 Europe PMC35 |
| 2024 | Barnes, A., Toson, B., Bryant, R. V., Mukherjee, S., Andrews, J. M., Spizzo, P., & Mountifield, R. (2024). Latent profiles of fatigue in inflammatory bowel disease. BMC Gastroenterology, 24(1), 7 pages. Scopus10 WoS9 Europe PMC6 |
| 2024 | Mathias, R. M., Chu, M. K. W., Edwards, S., Day, A. S., Ma, C., Jairath, V., & Bryant, R. V. (2024). Meta-analysis: Intestinal ultrasound to evaluate colonic contents and constipation.. Alimentary pharmacology & therapeutics, 60(1), 6-16. Scopus11 WoS10 Europe PMC7 |
| 2024 | Mathias, R. M., Chu, M. K. W., Edwards, S., Day, A. S., Ma, C., Jairath, V., & Bryant, R. V. (2024). Editorial: Sonographic assessment of colonic content-A new tool for constipation? Authors' reply.. Alimentary pharmacology & therapeutics, 60(2), 296-297. |
| 2024 | Melton, S. L., Day, A. S., Bryant, R. V., & Halmos, E. P. (2024). Revolution in diet therapy for inflammatory bowel disease. Jgh Open, 8(7), 10 pages. Scopus16 WoS16 Europe PMC14 |
| 2024 | Bogatic, D., & Bryant, R. V. (2024). Letter: Microbial manipulation for primary sclerosing cholangitis-associated inflammatory bowel disease—hope on the horizon. Alimentary Pharmacology and Therapeutics, 60(4), 535-536. |
| 2024 | Little, R. D., McKenzie, J., Srinivasan, A., Hilley, P., Gilmore, R. B., Chee, D., . . . Sparrow, M. P. (2024). Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial. BMJ Open, 14(7), 8 pages. Scopus5 WoS5 Europe PMC5 |
| 2024 | Mathias, R. M., & Bryant, R. V. (2024). Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 60(6), 833-834. Scopus1 WoS1 Europe PMC1 |
| 2024 | Barnes, A., Bryant, R. V., Mukherjee, S., Spizzo, P., & Mountifield, R. (2024). Sleep quality is associated with reduced quality of life in inflammatory bowel disease through its interaction with pain. Jgh Open, 8(8), 8 pages. Scopus4 WoS3 Europe PMC3 |
| 2024 | Barnes, A., Bryant, R. V., Mukherjee, S., Andrews, J. M., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Depression influences fatigue in inflammatory bowel disease amongst other factors: a structural modelling approach. Therapeutic Advances in Gastroenterology, 17, 12 pages. Scopus6 WoS5 Europe PMC3 |
| 2024 | Bogatic, D., & Bryant, R. V. (2024). Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post-operative recurrence of Crohn's disease. Alimentary Pharmacology and Therapeutics, 60(10), 1501-1502. |
| 2024 | Lu, C., Rosentreter, R., Parker, C. E., Remillard, J., Wilson, S. R., Baker, M. E., . . . Rieder, F. (2024). International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement. Lancet Gastroenterology and Hepatology, 9(12), 1101-1110. Scopus47 WoS38 Europe PMC27 |
| 2023 | Raja, S. S., Bryant, R. V., Costello, S. P., Barnett, M., Schubert, J., & Rayner, C. K. (2023). Systematic Review of therapies for refractory ulcerative proctitis.. J Gastroenterol Hepatol, 38(4), 496-509. Scopus17 WoS13 Europe PMC14 |
| 2023 | Pudipeddi, A., Fung, C., Christensen, B., Bryant, R. V., Subramaniam, K., Chetwood, J., . . . Leong, R. W. (2023). Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists. World Journal of Gastroenterology, 29(2), 378-389. Scopus7 WoS7 Europe PMC6 |
| 2023 | Tucker, E. C., Haylock-Jacobs, S., Rapaic, M., Dann, L. M., Bryant, R. V., & Costello, S. P. (2023). Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation. Jgh Open, 7(3), 172-177. Scopus11 WoS12 Europe PMC10 |
| 2023 | Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Spizzo, P., . . . Mountifield, R. (2023). Simple Novel Screening Tool for Obstructive Sleep Apnea in Inflammatory Bowel Disease. Crohn S and Colitis 360, 5(2), 8 pages. Scopus3 WoS3 Europe PMC3 |
| 2023 | Bryant, R. V., & Travis, S. P. L. (2023). APOLLO Has Landed: PROMS and Histology in UC. Journal of Crohn S and Colitis, 17(7), 1027-1028. |
| 2023 | Schubert, J. P., Ingram, P. R., Warner, M. S., Rayner, C. K., Roberts-Thomson, I. C., Costello, S. P., & Bryant, R. V. (2023). Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance. Internal Medicine Journal, 53(11), 1972-1978. Scopus6 WoS6 Europe PMC4 |
| 2023 | St-Pierre, J., Delisle, M., Kheirkhahrahimabadi, H., Goodsall, T. M., Bryant, R. V., Christensen, B., . . . Novak, K. L. (2023). Bedside Intestinal Ultrasound Performed in an IBD Urgent Assessment Clinic Improves Clinical Decision Making and Resource Utilization. Crohn's & Colitis 360, 5(4), 1-9. Scopus13 WoS12 Europe PMC7 |
| 2023 | Li, A., Bowen, J. M., Ball, I. A., Wilson, S., Yong, A., Yeung, D. T., . . . Wardill, H. R. (2023). Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study. Biomedicines, 11(12), 1-9. Scopus6 WoS6 Europe PMC4 |
| 2022 | Soo, W. T., Costello, S. P., & Bryant, R. V. (2022). Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 67(1), 8-10. Scopus2 WoS2 Europe PMC2 |
| 2022 | Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2022). Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study. Journal of Human Nutrition and Dietetics, 35(1), 234-244. Scopus49 WoS46 Europe PMC43 |
| 2022 | Santos-Paulo, S., Costello, S. P., Forster, S. C., Travis, S. P., & Bryant, R. V. (2022). The gut microbiota as a therapeutic target for obesity: A scoping review. Nutrition Research Reviews, 35(2), 207-220. Scopus29 WoS25 Europe PMC19 |
| 2022 | Ilvemark, J. F. K. F., Hansen, T., Goodsall, T. M., Seidelin, J. B., Al- Farhan, H., Allocca, M., . . . Wilkens, R. (2022). Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement. Journal of Crohn S and Colitis, 16(4), 554-580. Scopus160 WoS160 Europe PMC131 |
| 2022 | Kucharzik, T., Tielbeek, J., Carter, D., Taylor, S. A., Tolan, D., Wilkens, R., . . . Rimola, J. (2022). ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease. Journal of Crohn S and Colitis, 16(4), 523-543. Scopus136 WoS123 Europe PMC114 |
| 2022 | Goodsall, T. M., & Bryant, R. V. (2022). Editorial: an accurate, reliable and responsive ultrasound activity score for Crohn’s disease? Sounds good to US. Alimentary Pharmacology and Therapeutics, 55(3), 360-361. Scopus1 WoS1 Europe PMC1 |
| 2022 | Schubert, J. P., Woodman, R. J., Mangoni, A. A., Rayner, C. K., Warner, M. S., Roberts-Thomson, I. C., . . . Bryant, R. V. (2022). Geospatial analysis of Helicobacter pylori infection in South Australia: should location influence eradication therapy?. Journal of gastroenterology and hepatology, 37(7), 1263-1274. Scopus9 WoS9 Europe PMC8 |
| 2022 | Lee, S. Z., Schubert, J. P., Prowse, S. J. B., & Bryant, R. V. (2022). Are we underutilising computer tomography colonography in Australia?. Internal Medicine Journal, 52(5), 864-867. Scopus4 WoS4 Europe PMC3 |
| 2022 | Day, A. S., Yao, C. K., Costello, S. P., Ruszkiewicz, A., Andrews, J. M., Gibson, P. R., & Bryant, R. V. (2022). Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study. Journal of Nutrition, 152(7), 1690-1701. Scopus51 WoS49 Europe PMC43 |
| 2022 | Madsen, G. R., Wilkens, R., Boysen, T., Burisch, J., Bryant, R., Carter, D., . . . Tolsgaard, M. (2022). The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey. Alimentary Pharmacology and Therapeutics, 56(2), 263-270. Scopus34 WoS33 Europe PMC31 |
| 2022 | Duong, T. A., Bryant, R. V., Andrews, J. M., & Lynch, K. D. (2022). Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease. Internal Medicine Journal, 52(6), 1070-1074. Scopus5 WoS5 Europe PMC5 |
| 2022 | Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., . . . Forster, S. C. (2022). Review article: the future of microbiome-based therapeutics. Alimentary Pharmacology and Therapeutics, 56(2), 192-208. Scopus172 WoS129 Europe PMC110 |
| 2022 | Al-Ani, A. H., Vaughan, R., Christensen, B., Bryant, R. V., & Novak, K. L. (2022). Treat to transmural healing: how to incorporate intestinal ultrasound into the treatment of inflammatory bowel disease. British Journal of Radiology, 95(1137), 12 pages. Scopus10 WoS11 Europe PMC11 |
| 2022 | Ma, C., Hanzel, J., Panaccione, R., Sandborn, W. J., D'Haens, G. R., Ahuja, V., . . . Jairath, V. (2022). CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology, 163(4), 950-964. Scopus75 WoS74 Europe PMC68 |
| 2022 | Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2022). Microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics, 57(1), 23-36. Scopus19 WoS18 Europe PMC15 |
| 2022 | Schubert, J. P., Rayner, C. K., Costello, S. P., Roberts-Thomson, I. C., Forster, S. C., & Bryant, R. V. (2022). Helicobacter pylori: Have potential benefits been overlooked?. JGH Open, 6(11), 735-737. Scopus6 WoS5 Europe PMC5 |
| 2021 | Goodsall, T. M., Nguyen, T. M., Parker, C. E., Ma, C., Andrews, J. M., Jairath, V., & Bryant, R. V. (2021). Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.. J Crohns Colitis, 15(1), 125-142. Scopus75 WoS70 Europe PMC62 |
| 2021 | Day, A. S., Wood, J. A., Halmos, E. P., & Bryant, R. V. (2021). Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic. Journal of the Academy of Nutrition and Dietetics, 121(2), 201-209. Scopus1 WoS1 Europe PMC1 |
| 2021 | Davis, R., Day, A., Barrett, J., Vanlint, A., Andrews, J. M., Costello, S. P., & Bryant, R. V. (2021). Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.. Journal of Human Nutrition and Dietetics, 34(2), 420-428. Scopus21 WoS21 Europe PMC22 |
| 2021 | Goodsall, T. M., Han, S., & Bryant, R. V. (2021). Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. Journal of Gastroenterology and Hepatology Australia, 36(6), 1550-1555. Scopus16 WoS19 Europe PMC18 |
| 2021 | Schubert, J. P., Gehlert, J., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., Mangoni, A. A., & Bryant, R. V. (2021). Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis. Journal of gastroenterology and hepatology, 36(6), 1450-1456. Scopus27 WoS28 Europe PMC24 |
| 2021 | Day, A. S., Davis, R., Costello, S. P., Yao, C. K., Andrews, J. M., & Bryant, R. V. (2021). The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. Journal of the Academy of Nutrition and Dietetics, 121(4), 688-708.e3. Scopus41 WoS34 Europe PMC29 |
| 2021 | Ma, C., Sedano, R., Almradi, A., Casteele, N. V., Parker, C. E., Guizzetti, L., . . . Jairath, V. (2021). An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials. Gastroenterology, 160(7), 2291-2302. Scopus102 WoS94 Europe PMC95 |
| 2021 | Goodsall, T. M., Jairath, V., Feagan, B. G., Parker, C. E., Nguyen, T. M., Guizzetti, L., . . . Ma, C. (2021). Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease. Alimentary Pharmacology and Therapeutics, 53(8), 873-886. Scopus70 WoS71 Europe PMC62 |
| 2021 | Goodsall, T. M., Jairath, V., Bryant, R. V., & Ma, C. (2021). Editorial: use of intestinal ultrasound in the scoring of Crohn’s disease activity in clinical trials – is it ready for prime time yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 53(8), 948-949. |
| 2021 | Goodsall, T. M., Noy, R., Nguyen, T. M., Costello, S. P., Jairath, V., & Bryant, R. V. (2021). Systematic review: Patient perceptions of monitoring tools in inflammatory bowel disease. Journal of the Canadian Association of Gastroenterology, 4(2), E31-E41. Scopus56 Europe PMC45 |
| 2021 | Bryant, R. V., Day, A. S., McGrath, K. C., Telfer, K., Yao, C. K., & Costello, S. P. (2021). Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis. Jgh Open, 5(9), 1099-1102. Scopus15 WoS13 Europe PMC13 |
| 2021 | Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2021). Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite, 167, 16 pages. Scopus88 WoS84 Europe PMC78 |
| 2021 | Prentice, R. E., Rentsch, C., Al-Ani, A. H., Zhang, E., Johnson, D., Halliday, J., . . . Christensen, B. (2021). SARS-CoV-2 vaccination in patients with inflammatory bowel disease.. GastroHep, 3(4), 212-228. Europe PMC9 |
| 2021 | Schubert, J. P., Warner, M. S., Rayner, C. K., Roberts-Thomson, I., Mangoni, A. A., Costello, S., & Bryant, R. V. (2021). Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years. Internal Medicine Journal, 52(9), 1554-1560. Scopus24 WoS22 Europe PMC14 |
| 2020 | Day, A., Wood, J., Melton, S., & Bryant, R. (2020). Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease. JGH Open, 4(2), 260-266. Scopus37 WoS36 Europe PMC33 |
| 2020 | Rajagopalan, A., Sathananthan, D., An, Y. K., Van De Ven, L., Martin, S., Fon, J., . . . Bryant, R. V. (2020). Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. Jgh Open, 4(2), 267-272. Scopus64 WoS56 Europe PMC50 |
| 2020 | Sathananthan, D., Rajagopalan, A., Van De Ven, L., Martin, S., Fon, J., Costello, S., & Bryant, R. V. (2020). Point-of-care gastrointestinal ultrasound in inflammatory bowel disease: An accurate alternative for disease monitoring. Jgh Open, 4(2), 273-279. Scopus21 WoS18 Europe PMC15 |
| 2020 | Costello, S. P., & Bryant, R. V. (2020). Editorial: faecal microbiota transplantation—the silver bullet for severe and fulminant Clostridioides difficile infection?. Alimentary Pharmacology and Therapeutics, 51(1), 180-181. |
| 2020 | Soo, W. T., Bryant, R. V., & Costello, S. P. (2020). Faecal microbiota transplantation: Indications, evidence and safety. Australian Prescriber, 43(2), 36-38. Scopus6 WoS6 Europe PMC5 |
| 2020 | Flanagan, E., Wright, E. K., Begun, J., Bryant, R. V., An, Y. -K., Ross, A. L., . . . Bell, S. J. (2020). Monitoring Inflammatory Bowel Disease in Pregnancy using Gastrointestinal Ultrasonography.. Journal of Crohn's & colitis, 14(10), 1405-1412. Scopus67 WoS58 Europe PMC53 |
| 2020 | Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Coronavirus disease 2019 (COVID-19) and implications for thiopurine use.. Med J Aust, 212(10), 490-490.e1. Scopus5 WoS5 Europe PMC5 |
| 2020 | Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). ABC of topical therapy in inflammatory bowel disease. Jgh Open, 4(4), 556-557. Scopus3 WoS3 Europe PMC2 |
| 2020 | Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough. Journal of Crohn S and Colitis, 14(10), 1341-1342. Scopus3 WoS2 Europe PMC2 |
| 2020 | Aysha, A. -A., Rentsch, C., Prentice, R., Johnson, D., Bryant, R. V., Ward, M. G., . . . Christensen, B. (2020). Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.. Intern Med J, 50(7), 798-804. Scopus12 WoS11 Europe PMC12 |
| 2020 | Vanlint, A. S., Kaazan, P., Kwok, M., Bryant, R. V., Ooi, M., Bak, N., & Costello, S. (2020). Lessons from practice Low attenuation lymphadenopathy on computed tomography leading to diagnosis of Whipple disease. Medical Journal of Australia, 213(4), 161-162.e1. |
| 2020 | Gill, M., Blacketer, C., Chitti, F., Telfer, K., Papanicolas, L., Dann, L. M., . . . Costello, S. P. (2020). Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank. Jgh Open, 4(5), 950-957. Scopus12 WoS11 Europe PMC9 |
| 2020 | Costello, S. P., Day, A., Yao, C. K., & Bryant, R. V. (2020). Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis.. BMJ Case Rep, 13(8), 3 pages. Scopus26 WoS21 Europe PMC25 |
| 2020 | Meyer, E. J., Mignone, E., Hade, A., Thiruvenkatarajan, V., Bryant, R. V., & Jesudason, D. (2020). Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy.. Diabetes Care, 43(11), e181-e184. Scopus28 WoS25 Europe PMC22 |
| 2019 | Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2019). Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflammatory bowel diseases, 25(3), 592-600. Scopus68 WoS67 Europe PMC58 |
| 2019 | Oakland, K., Kahan, B. C., Guizzetti, L., Martel, M., Bryant, R. V., Brahmania, M., . . . Jairath, V. (2019). Development, Validation, and Comparative Assessment of an International Scoring System to Determine Risk of Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology, 17(6), 1121. Scopus44 WoS39 Europe PMC33 |
| 2019 | Bryant, R. V., Schultz, C. G., Ooi, S., Goess, C., Costello, S. P., Vincent, A. D., . . . Andrews, J. M. (2019). Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Inflammatory bowel diseases, 25(6), e62-e63. |
| 2019 | Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P., . . . Andrews, J. M. (2019). Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA - Journal of the American Medical Association, 321(2), 156-164. Scopus829 WoS744 Europe PMC681 |
| 2019 | Costello, S., & Bryant, R. (2019). Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Internal Medicine Journal, 49(2), 148-151. Scopus11 WoS9 Europe PMC9 |
| 2019 | Wardill, H., Secombe, K., Bryant, R., Hazenberg, M. D., & Costello, S. (2019). Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine, 44, 730-740. Scopus72 WoS64 Europe PMC56 |
| 2019 | Bryant, R. V., & Costello, S. P. (2019). Editorial: assessing histological disease activity in Crohn’s disease—a call for standardisation of mucosal biopsy location. Alimentary Pharmacology and Therapeutics, 50(1), 103-104. Scopus3 WoS3 Europe PMC2 |
| 2019 | Biswas, S., Bryant, R. V., & Travis, S. (2019). Interfering with leukocyte trafficking in Crohn's disease. Best Practice and Research Clinical Gastroenterology, 38-39, 8 pages. Scopus25 WoS23 Europe PMC17 |
| 2019 | Roberts-Thomson, I. C., Bryant, R. V., & Costello, S. P. (2019). Uncovering the cause of ulcerative colitis.. JGH open : an open access journal of gastroenterology and hepatology, 3(4), 274-276. Scopus24 WoS22 Europe PMC17 |
| 2019 | Liu, J., Andrews, J. M., Sammour, T., Bryant, R. V., Grafton, R., Simpson, E., . . . Nixon, C. (2019). Benefits of exclusive enteral nutrition in adults with complex active Crohn's disease: A case series of 13 consecutive patients. Crohn's and Colitis 360, 1(3), 1-7. Scopus4 WoS4 |
| 2018 | Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Knight, E., Lau, S. -Y., . . . Andrews, J. (2018). Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice. Journal of gastroenterology and hepatology, 33(3), 599-607. Scopus42 WoS38 Europe PMC36 |
| 2018 | Schwerd, T., Bryant, R., Pandey, S., Capitani, M., Meran, L., Cazier, J. -B., . . . Uhlig, H. (2018). NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.. Mucosal immunology, 11(2), 562-574. Scopus89 WoS79 Europe PMC82 |
| 2018 | Bryant, R. V., Friedman, A. B., Wright, E. K., Taylor, K. M., Begun, J., Maconi, G., . . . Gibson, P. R. (2018). Gastrointestinal ultrasound in inflammatory bowel disease: An underused resource with potential paradigm-changing application. Gut, 67(5), 973-985. Scopus170 WoS159 Europe PMC136 |
| 2018 | Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2018). Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of Myopenia and Osteopenia. Nutrients, 10(9), 1192-1-1192-17. Scopus72 WoS70 Europe PMC61 |
| 2017 | Bezzio, C., Bryant, R. V., Manes, G., Maconi, G., & Saibeni, S. (2017). New horizons in the imaging of perianal Crohn’s disease: transperineal ultrasonography. Expert Review of Gastroenterology and Hepatology, 11(6), 523-530. Scopus21 WoS19 Europe PMC18 |
| 2017 | Costello, S., Soo, W., Bryant, R., Jairath, V., Hart, A., & Andrews, J. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology and Therapeutics, 46(3), 213-224. Scopus244 WoS218 Europe PMC200 |
| 2017 | Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 46(6), 631-632. |
| 2017 | Bryant, R. V., Prowse, S. J. B., Nguyen-Hoang, A., & Lewis, M. C. (2017). Gastrointestinal: Adenocarcinoma in ileal Crohn's disease: A devil in disguise. Journal of Gastroenterology and Hepatology Australia, 32(9), 1535. Scopus2 WoS2 Europe PMC2 |
| 2017 | Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., . . . Leong, R. W. (2017). Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 46(11-12), 1037-1053. Scopus280 WoS247 Europe PMC223 |
| 2017 | Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., MacOni, G., . . . Dietrich, C. (2017). How to perform gastrointestinal ultrasound: Anatomy and normal findings. World Journal of Gastroenterology, 23(38), 6931-6941. Scopus87 WoS71 Europe PMC57 |
| 2017 | Guirgis, M., Wendt, E., Wang, L. M., Walsh, A., Burger, D., Bryant, R. V., . . . Keshav, S. (2017). Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis. Journal of Crohn's and Colitis, 11(4), jjw174. Scopus14 WoS14 Europe PMC9 |
| 2016 | Griffiths, E., McDonald, C., Bryant, R., Devitt, P., Bright, T., Holloway, R., & Thompson, S. (2016). Retrospective analysis of surgery and trans-arterial embolization for major non-variceal upper gastrointestinal bleeding. ANZ Journal of Surgery, 86(5), 381-385. Scopus12 WoS11 Europe PMC10 |
| 2016 | Bennett, A. L., Moore, D., Bampton, P. A., Bryant, R. V., & Andrews, J. M. (2016). Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World Journal of Gastroenterology, 22(8), 2611-2620. Scopus42 WoS38 Europe PMC33 |
| 2016 | Hughes, P., Costello, S., Bryant, R., & Andrews, J. (2016). Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications. American Journal of Physiology, 311(3), G501-G513. Scopus25 WoS19 Europe PMC17 |
| 2016 | Walsh, A., Bryant, R., & Travis, S. (2016). Current best practice for disease activity assessment in IBD. Nature Reviews Gastroenterology and Hepatology, 13(10), 567-579. Scopus204 WoS188 Europe PMC168 |
| 2016 | Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., Maconi, G., . . . Dietrich, C. (2016). WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice. Ultrasound in Medicine and Biology, 42(12), 2732-2742. Scopus77 WoS67 Europe PMC51 |
| 2016 | Bryant, R. V., Burger, D. C., Delo, J., Walsh, A. J., Thomas, S., Von Herbay, A., . . . Travis, S. P. L. (2016). Beyond endoscopic mucosal healing in UC: Histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut, 65(3), 408-414. Scopus384 WoS371 Europe PMC338 |
| 2015 | Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2015). Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 41(9), 895-906. Scopus139 WoS128 Europe PMC120 |
| 2015 | Bryant, R. V., & Andrews, J. M. (2015). Letter: low muscle mass and disordered eating as causes of osteopenia in inflammatory bowel disease - authors' reply. Alimentary Pharmacology and Therapeutics, 41(12), 1304-1305. Scopus1 WoS1 Europe PMC1 |
| 2015 | Bryant, R. V., Costello, S. P., & Andrews, J. M. (2015). Editorial: Untangling symptoms from mucosal healing in UC - A note of caution for patient-reported outcomes. Alimentary Pharmacology and Therapeutics, 42(11-12), 1327-1328. Scopus1 WoS1 Europe PMC1 |
| 2015 | Bryant, R. V., Brain, O., & Travis, S. P. L. (2015). Conventional drug therapy for inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 50(1), 90-112. Scopus72 WoS67 Europe PMC58 |
| 2015 | Bryant, R. V., Sandborn, W. J., & Travis, S. P. L. (2015). Introducing vedolizumab to clinical practice: Who, when, and how?. Journal of Crohn S and Colitis, 9(4), 356-366. Scopus53 WoS44 Europe PMC42 |
| 2015 | Bryant, R. V., Winer, S., Travis, S. P. L., & Riddell, R. H. (2015). Response to Villanacci et. al. Journal of Crohn S Colitis, 9(5), 429. |
| 2015 | Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., . . . Colombel, J. F. (2015). Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. American Journal of Gastroenterology, 110(9), 1324-1338. Scopus1718 WoS1562 Europe PMC1462 |
| 2014 | Bryant, R., Jairath, V., Curry, N., & Travis, S. (2014). Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?. Journal of Crohn's and Colitis, 8(2), 166-171. Scopus32 WoS26 Europe PMC21 |
| 2014 | Bryant, R. V., Winer, S., SPL, T., & Riddell, R. H. (2014). Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. Journal of Crohn S and Colitis, 8(12), 1582-1597. Scopus266 WoS258 Europe PMC232 |
| 2013 | Bryant, R., Trott, M., Bartholomeusz, F., & Andrews, J. (2013). Systematic review: Body composition in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 38(3), 213-225. Scopus162 WoS152 Europe PMC135 |
| 2013 | Bryant, R., Trott, M., Bennett, A., Bampton, P., Moore, D., & Andrews, J. (2013). Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. Internal Medicine Journal, 43(11), 1171-1176. Scopus5 WoS4 Europe PMC4 |
| 2013 | Bryant, R., Kuo, P., Williamson, K., Yam, C., Schoeman, M., Holloway, R., & Nguyen, Q. (2013). Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. Gastrointestinal Endoscopy, 78(4), 576-583. Scopus112 WoS97 Europe PMC88 |
| 2013 | Bryant, R., Schoeman, S., & Schoeman, M. (2013). Shorter preparation to procedure interval for colonoscopy improves quality of bowel cleansing. Internal Medicine Journal, 43(2), 162-168. Scopus20 WoS18 Europe PMC17 |
| 2012 | Bryant, R. V., Holloway, R. H., & Nguyen, N. Q. (2012). Gastrointestinal: role of endoscopic ultrasound in the evaluation of pseudoachalasia. Journal of Gastroenterology and Hepatology, 27(6), 1128. Scopus10 WoS8 Europe PMC6 |
| 2011 | Bryant, R., Van Langenberg, D., Holtmann, G., & Andrews, J. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology, 26(5), 916-923. Scopus81 WoS74 Europe PMC66 |
| 2011 | Bryant, R. V., Schoeman, S. N., & Schoeman, M. N. (2011). Split vs single day preparation and colonoscopy outcomes in a large single Australian centre. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26, 75. |
| 2010 | Andrews, J., Bryant, R., Van Langenberg, D., & Holtmann, G. (2010). Are all symptoms in patients in IBD due to occult inflammation. American Journal of Gastroenterology, 105(12), 2703. Scopus3 WoS2 |
| Year | Citation |
|---|---|
| 2025 | Han, S., Martin, S. R., & Bryant, R. V. (2025). Opportunistic Infections. In Inflammatory Bowel Disease Nursing Manual (pp. 259-279). Springer Nature Switzerland. DOI |
| 2019 | Gill, M., & Bryant, R. V. (2019). Inflammatory Bowel Disease: Diagnosis and Management. In Gastroenterology for General Surgeons (pp. 55-73). Springer International Publishing. DOI Scopus1 |
| 2019 | Martin, S. R., & Bryant, R. V. (2019). Opportunistic Infections. In Inflammatory Bowel Disease Nursing Manual (pp. 189-204). Springer International Publishing. DOI Scopus1 |
| Year | Citation |
|---|---|
| 2026 | Mathias, R. M., Plush, S. L., Edwards, L. E., Bogatic, D., Bibb, L., Goodsall, T. M., . . . Bryant, R. V. (2026). Intestinal Ultrasound Adds Diagnostic Value and Safety to a Dietitian-Led Clinic for Disorders of Gut–Brain Interaction. In Jgh Open Vol. 10 (pp. 139-140). Australia: WILEY. DOI |
| 2026 | Fehily, S., Wright, E. K., Bogatic, D., Wilson-O'brien, A., Basnayake, C., Stanley, A., . . . Kamm, M. A. (2026). Faecal microbiota transplantation for active Crohn's disease: The MIRO (Microbial Restoration) randomised placebo-controlled trial.. In JOURNAL OF CROHNS & COLITIS Vol. 20 (pp. 2 pages). OXFORD UNIV PRESS. DOI |
| 2025 | Tucker, E. C., Angelica, B., Mathias, R. M., Edwards, L., Bryant, R. V., & Costello, S. P. (2025). Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia. In Open Forum Infectious Diseases Vol. 12 (pp. 7 pages). United States: OXFORD UNIV PRESS INC. DOI Scopus1 WoS2 Europe PMC1 |
| 2025 | Tan, J., Saluja, H., Naidu, J., Nind, G., Bryant, R. V., & Lidums, I. (2025). Short-acting versus long-acting octreotide for management of refractory bleeding due to gastrointestinal angiodysplasia and gastric antral vascular ectasia: Case series and lessons learnt. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 40 (pp. 180). WILEY. |
| 2024 | Goodsall, T. M., Day, A. S., Andrews, J. M., Ruszkiewicz, A., Ma, C., & Bryant, R. V. (2024). Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study. In Inflammatory Bowel Diseases Vol. 30 (pp. 190-195). England: OXFORD UNIV PRESS INC. DOI Scopus27 WoS29 Europe PMC22 |
| 2023 | Schubert, J., Tay, A., Lee, K. H. C., Leong, L., Rayner, C., Warner, W., . . . Bryant, R. (2023). Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance, phylogenetic patterns, and virulence mutations. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 (pp. 221). Australia: WILEY. DOI Scopus3 WoS3 Europe PMC3 |
| 2022 | Plush, S., Broad, L., Bryant, R. V., Shin, S. H., Kumar, S., & Day, A. (2022). Most referrals for functional gastrointestinal disorders are inadequate: Findings from a clinical audit of a tertiary gastroenterology service waitlist. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 200). WILEY. WoS2 |
| 2022 | An, Y. -K., Khoo, E., Lindsay, N., Amiss, A., Fernandes, R., Thin, L., . . . Begun, J. (2022). Gastrointestinal ultrasound predicts need for rescue therapy in a multicenter prospective cohort of patients with acute severe ulcerative colitis: USUC study, including the GENIUS cohort. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 147). WILEY. |
| 2022 | Tucker, E., Haylock-Jacobs, S., Bryant, R. V., & Costello, S. (2022). Stool donor screening eligibility and retention with a Therapeutic Goods Order 105-compliant stool donor screening program for fecal microbiota transplantation. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 208). WILEY. |
| 2021 | Schubert, J. P., Woodman, R. J., Mangoni, A. A., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., & Bryant, R. V. (2021). Geospatial analysis of Helicobacter pylori infection in the Greater Adelaide region over 20 years: Should location influence choice of eradication therapy?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 137-138). Virtual online: WILEY. |
| Year | Citation |
|---|---|
| 2018 | Rajagopalan, A., Sathananthan, D., Van De Ven, L., Martin, S., Fon, J., Costello, S. P., & Bryant, R. V. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Acceptability, tolerability, and impact on illness-related knowledge. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2018 | Sathananthan, D., Rajagopalan, A., Van De Ven, L., Fon, J., Costello, S. P., & Bryant, R. V. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Accuracy compared with colonoscopy and fecal calprotectin. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2016 | Bryant, R. V., Costello, S. C., Schoeman, S., Sathananthan, D., Lau, S. Y., Schoeman, M. N., . . . Andrews, J. M. (2016). Treat to target' in ulcerative colitis (UC) in the Australian setting: current practice and potential barriers? A multi-site cross-sectional evaluation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2016 | Bryant, R. V., Costello, S. C., Tee, D., Schoeman, S., Mountifield, R., & Andrews, J. M. (2016). Australian gastroenterologists' perceptions of 'treat to target' recommendations for ulcerative colitis: a survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2015 | Pilichiewicz, A. N., Goess, C., Linedale, E., Ooi, S. J., Bryant, R. V., Grafton, R., . . . Andrews, J. M. (2015). Nutrient intake in patients with inflammatory bowel disease: Are they meeting their dietary requirements?. Poster session presented at the meeting of Abstracts of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley. DOI |
| 2014 | Bryant, R. V., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. M. (2014). SARCOPAENIA MEASURED BY DXA IS COMMON IN IBD PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2014 | Lim, A. H., Ooi, S. Y., Bryant, R. V., Schultz, C. G., Goess, C., Grafton, R., . . . Andrews, J. M. (2014). The effects of vitamin D deficiency in patients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Broadbeach, Qld.: Wiley. DOI |
| 2012 | Nguyen, N. Q., Bryant, R. V., Kuo, P., Williamson, K. D., Schoeman, M., & Holloway, R. H. (2012). Risk Stratification With Glasgow-Blatchford Bleeding Score for Hospitalized Patients With Upper Gastrointestinal Bleeding Can Avoid the Needs for Urgent Endo-Therapy. Poster session presented at the meeting of GASTROINTESTINAL ENDOSCOPY. San Diego, CA: MOSBY-ELSEVIER. WoS2 |
| 2012 | Rahman, A. H. A., Hrycek, C., Bryant, R. V., Andrews, J., Nguyen, N., Schoeman, M., & Holloway, R. (2012). Is there a 'weekend effect' among patients referred to a dedicated 'haematemesis and melaena' service?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Adelaide, SA: Wiley. DOI |
| Year | Citation |
|---|---|
| 2024 | Barnes, A., Bryant, R., Mukherjee, S., Spizzo, P., & Mountifield, R. (2024). Insomnia is associated with reduced quality of life in inflammatory bowel disease. DOI |
| 2023 | Li, A., Bowen, J. M., Ball, I., Wilson, S., Yong, A., Yeung, D., . . . Wardill, H. (2023). Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study. DOI |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2026 | Principal Supervisor | Determinants and real-world outcomes of transmural healing in ulcerative colitis | Master of Philosophy | Master | Full Time | Dr Benjamin Ngoi |
| 2025 | Co-Supervisor | Investigating Gut Microbial Hydrogen Sulphide (H2S) as a Biomarker and Therapeutic Target for Ulcerative Colitis | Doctor of Philosophy | Doctorate | Part Time | Miss Kate Collins |
| 2024 | Principal Supervisor | Microbial manipulation as treatment for primary sclerosing cholangitis | Doctor of Philosophy | Doctorate | Full Time | Dr Damjana Bogatic |
| 2023 | Principal Supervisor | Intestinal ultrasound as a novel tool to assess luminal contents in inflammatory and functional gastrointestinal disorders | Doctor of Philosophy | Doctorate | Full Time | Dr Ryan Mathias |
| 2023 | Principal Supervisor | Evaluating the inflammatory potential of dietary protein in inflammatory bowel disease | Doctor of Philosophy | Doctorate | Full Time | Miss Rachel Hannah Davis |
| 2023 | Co-Supervisor | Faecal Microbiota Transplant (FMT) as a safe and efficacious therapeutic alternative for refractory proctitis | Doctor of Philosophy | Doctorate | Full Time | Dr Sreecanth Raja |
| 2022 | Principal Supervisor | Dietitian-first services: application of extended scope dietetics within gastroenterology services. | Doctor of Philosophy | Doctorate | Full Time | Miss Samantha Plush |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 - 2026 | Principal Supervisor | Intestinal ultrasound as a novel tool to assess luminal contents in inflammatory and functional gastrointestinal disorders | Doctor of Philosophy | Doctorate | Full Time | Dr Ryan Michael Mathias |
| 2021 - 2024 | Co-Supervisor | Improving treatment outcomes and prognosticating gastric cancer risk in patients with Helicobacter pylori infection | Doctor of Philosophy | Doctorate | Full Time | Mr Jonathon Paul Schubert |
| 2021 - 2024 | Co-Supervisor | Defining and validating the role of intestinal ultrasound for assessment of inflammatory bowel disease | Doctor of Philosophy | Doctorate | Full Time | Dr Tom Goodsall |
| 2018 - 2021 | Co-Supervisor | Exploring a patient-centred, diet-focused treatment paradigm for Inflammatory Bowel Disease | Doctor of Philosophy | Doctorate | Full Time | Mrs Alice Sarah Day |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2018 - ongoing | Principal Supervisor | Dietetic | Flinders University | - | Honours | - | Rachel Davis |
| 2018 - ongoing | Principal Supervisor | Gastroenterology Advanced Training Research Project | University of Adelaide | - | Other | - | Dr Arvind Rajagopalan |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2021 - ongoing | Chair | Executive Committee | Gastroenterology Network of Intestinal Ultrasound (GENIUS) | Australia |
| 2019 - ongoing | Member | IBD Faculty | Gastroenterological Society of Australia | Australia |
| 2014 - ongoing | Member | Conjoint Committee Recognition of Training Gastrointestinal Endoscopy, Upper Endoscopy and Colonoscopy, Gastroenterological Society of Australia (GESA) | Gastroenterological Society of Australia (GESA) | Australia |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2015 - ongoing | Member | Crohn’s Colitis Foundation | Australia |
| 2013 - ongoing | Member | European Crohn’s and Colitis Organisation | Denmark |
| 2013 - ongoing | Member | British Society of Gastroenterology | Ukraine |
| 2012 - ongoing | Member | American Gastroenterology Association | United States |
| 2011 - ongoing | Member | Gastroenterological Society of Australia | Australia |
| 2010 - ongoing | Member | Royal Australasian College of Physicians | Australia |
| 2008 - 2012 | Member | Royal Adelaide Hospital Resident Medical Officers Association | Australia |
| Date | Engagement Type | Partner Name |
|---|---|---|
| 2023 - ongoing | Consultant | BiomeBank |
Connect With Me
External Profiles
